PALATIN TECHNOLOGIES, INC. Line of Credit Facility, Increase, Accrued Interest
PALATIN TECHNOLOGIES, INC. (PTN) reported Line of Credit Facility, Increase, Accrued Interest of $2.30 million for the 9-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityIncreaseAccruedInterest · last filed 2023-05-15
- PALATIN TECHNOLOGIES, INC. line of credit facility, increase, accrued interest for the quarter ending 2023-03-31 was $0.00.
- PALATIN TECHNOLOGIES, INC. line of credit facility, increase, accrued interest for the quarter ending 2022-12-31 was $0.00.
- PALATIN TECHNOLOGIES, INC. line of credit facility, increase, accrued interest for the quarter ending 2022-09-30 was $2.30M, a 0.00% change year-over-year.
- PALATIN TECHNOLOGIES, INC. line of credit facility, increase, accrued interest for the quarter ending 2022-06-30 was $0.00.
- PALATIN TECHNOLOGIES, INC. line of credit facility, increase, accrued interest for fiscal 2022 was $2.30M.
| Period end | Line of Credit Facility, Increase, Accrued Interest 3 month | Line of Credit Facility, Increase, Accrued Interest 6 month | Line of Credit Facility, Increase, Accrued Interest 9 month | Line of Credit Facility, Increase, Accrued Interest 12 month |
|---|---|---|---|---|
| 2023-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15 | $0.00 derived: sum of 2 quarters · filed 2023-05-15 | $2.30M 10-Q · filed 2023-05-15 | $2.30M derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-14 | $2.30M 10-Q · filed 2023-02-14 | $2.30M derived: sum of 3 quarters · filed 2023-02-14 | $2.30M derived: sum of 4 quarters · filed 2023-02-14 |
| 2022-09-30 | $2.30M 10-Q · filed 2022-11-14 | $2.30M derived: sum of 2 quarters · filed 2022-11-14 | $2.30M derived: sum of 3 quarters · filed 2022-11-14 | $2.30M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-22 | $0.00 derived: sum of 2 quarters · filed 2022-09-22 | $0.00 derived: sum of 3 quarters · filed 2022-09-22 | $2.30M 10-K · filed 2022-09-22 |
| 2022-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | $0.00 derived: sum of 2 quarters · filed 2022-05-16 | $2.30M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | $2.30M 10-Q · filed 2022-02-14 | ||
| 2021-09-30 | $2.30M 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |